Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

SRC-family kinase (SFK) inhibitor

DRUG CLASS:

SRC-family kinase (SFK) inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

NRAS mutation	Melanoma	NRAS mutation	Melanoma	CCT241161 + CCT196969 Sensitive: D – Preclinical CCT241161 + CCT196969 Sensitive : D	CCT241161 + CCT196969 Sensitive: D – Preclinical CCT241161 + CCT196969 Sensitive : D
NRAS mutation	Melanoma	NRAS mutation	Melanoma	SAB298 Sensitive: D – Preclinical SAB298 Sensitive : D	SAB298 Sensitive: D – Preclinical SAB298 Sensitive : D
BRAF mutation	Thyroid Gland Carcinoma	BRAF mutation	Thyroid Gland Carcinoma	SU6656 Sensitive: D – Preclinical SU6656 Sensitive : D	SU6656 Sensitive: D – Preclinical SU6656 Sensitive : D
RET-PTC1 rearrangement	Thyroid Gland Papillary Carcinoma	RET-PTC1 rearrangement	Thyroid Gland Papillary Carcinoma	CI-1040 + SU6656 Sensitive: D – Preclinical CI-1040 + SU6656 Sensitive : D	CI-1040 + SU6656 Sensitive: D – Preclinical CI-1040 + SU6656 Sensitive : D
NRAS mutation	Melanoma	NRAS mutation	Melanoma	CCT241161 Sensitive: D – Preclinical CCT241161 Sensitive : D	CCT241161 Sensitive: D – Preclinical CCT241161 Sensitive : D